Valuation : ArcticZymes Technologies ASA

Market Cap 1.08B 117M 100M 95.11M 86.21M 162M 11.14B 163M 1.13B 434M 5.67B 438M 428M 17.91B P/E 2026 *
69.1x
P/E 2027 * 39.7x
Enterprise Value 804M 86.59M 74.61M 70.64M 64.03M 120M 8.27B 121M 839M 323M 4.21B 325M 318M 13.3B EV / Sales 2026 *
5.74x
EV / Sales 2027 * 4.85x
Free-Float
82.59%
Yield 2026 *
-
Yield 2027 * -
1 day-1.40%
1 week+0.95%
Current month+1.44%
1 month+9.00%
3 months+1.44%
6 months-1.40%
Current year+2.91%
1 week 20.7
Extreme 20.7
21.8
1 month 19.95
Extreme 19.95
22
Current year 18.3
Extreme 18.3
26.6
1 year 18.3
Extreme 18.3
31.4
3 years 12.34
Extreme 12.34
43.2
5 years 12.34
Extreme 12.34
100
10 years 3.5
Extreme 3.5
114.4
Manager TitleAgeSince
Chief Executive Officer - 18/09/2023
Director of Finance/CFO 51 01/10/2014
Chief Tech/Sci/R&D Officer 43 -
Director TitleAgeSince
Chairman 64 26/06/2024
Director/Board Member 62 26/06/2024
Director/Board Member - -
Date Insider Type Main position Quantity % Market Cap. Importance
8/14/25 A Buy

Director

2,852 0.0056%
6/4/25 A Buy

Chief Operating Officer

3,400 0.0067%
5/14/25 A Exercice

Chief Operating Officer

15,000 0.0294%
Change 5-day change 1-year change 3-year change Capi.($)
-1.40%+0.95%-19.39%-29.22% 117M
-0.65%-2.93%+47.70%+86.30% 994B
-0.29%-3.51%+49.15%+61.95% 640B
+0.83%+0.26%+17.76%+70.10% 454B
-0.38%-3.59%+30.13%+34.14% 337B
-0.09%-13.54%+13.34%+24.74% 261B
-0.43%-2.48%-0.73%+10.64% 246B
-1.34%-13.70%+36.53%+46.70% 204B
-3.44%-7.51%-20.63%-58.97% 190B
-0.75%-4.82%+25.46%+85.90% 178B
Average -0.79%-5.09%+17.93%+33.23% 350.49B
Weighted average by Cap. -0.51%-4.42%+30.96%+54.65%

Financials

2026 *2027 *
Net sales 140M 15.08M 12.99M 12.3M 11.15M 20.92M 1.44B 21.02M 146M 56.18M 733M 56.62M 55.38M 2.32B 160M 17.25M 14.86M 14.07M 12.75M 23.93M 1.65B 24.05M 167M 64.26M 838M 64.77M 63.35M 2.65B
Net income 15.66M 1.69M 1.45M 1.38M 1.25M 2.34M 161M 2.35M 16.34M 6.28M 81.95M 6.33M 6.19M 259M 27.28M 2.94M 2.53M 2.4M 2.17M 4.08M 281M 4.1M 28.47M 10.95M 143M 11.03M 10.79M 451M
Net Debt -279M -29.99M -25.84M -24.47M -22.18M -41.61M -2.87B -41.82M -291M -112M -1.46B -113M -110M -4.61B -306M -32.98M -28.42M -26.91M -24.39M -45.76M -3.15B -45.99M -320M -123M -1.6B -124M -121M -5.07B
Logo ArcticZymes Technologies ASA
Arcticzymes Technologies ASA is a Norway-based holding company providing support functions to the ArcticZymes AS subsidiary including distribution, administration, finance, Information Technology (IT) and quality assurance. As a life science company, Arcticzymes Technologies ASA is focused on the development, manufacturing, and commercialization of novel and high-quality recombinant enzymes for use in molecular research, In Vitro Diagnostics (IVD) and biomanufacturing. Some of the key features of the Company’s enzymes include cold activeness and salt tolerance. The Company’s divided into two operating segments; Enzymes and Corporate. Arcticzymes established logistic hubs in the United States and the Netherlands to serve its customers more efficiently.
Employees
51
Date Price Change Volume
11/09/26 NOK 21.20 -1.40% 5,886
10/09/26 NOK 21.50 +3.86% 15,659
09/09/26 NOK 20.70 0.00% 13,240
08/09/26 NOK 20.70 -1.90% 14,801
07/09/26 NOK 21.10 +0.48% 21,851
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
21.20NOK
Average target price
28.00NOK
Spread / Average Target
+32.08%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!